Efficacy and safety of baricitinib in Japanese patients with autoinflammatory type I interferonopathies (NNS/CANDLE, SAVI, And AGS)

Efficacy and safety of baricitinib in Japanese patients with autoinflammatory type I interferonopathies (NNS/CANDLE, SAVI, And AGS)

Abstract Background This study evaluated the efficacy and safety of baricitinib (Janus kinase-1/2 inhibitor), in adult and pediatric Japanese patients with Nakajo-Nishimura syndrome/chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature (NNS/CANDLE), stimulator of inter...

Full description

Bibliographic Details
Main Authors: Nobuo Kanazawa, Taeko Ishii, Yasushi Takita, Atsushi Nishikawa, Ryuta Nishikomori
Format: Article
Language:English
Published: BMC 2023-04-01
Series:Pediatric Rheumatology Online Journal
Subjects:
AGS
Autoinflammatory type I interferonopathies
Baricitinib
NNS/CANDLE
SAVI
Online Access:https://doi.org/10.1186/s12969-023-00817-8

Internet

https://doi.org/10.1186/s12969-023-00817-8

Similar Items